Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director

23-May-2006

Med BioGene Inc. (MBI) announced the appointment of Erinn B. Broshko as Chief Executive Officer and a director of MBI.

Prior to joining MBI, Mr. Broshko was a corporate and securities lawyer with the Vancouver law firm of Farris, Vaughan, Wills & Murphy LLP. Mr. Broshko's legal practice was focussed primarily on biotechnology companies. Mr. Broshko holds a B.A. (hons) and M.A. from the University of Saskatchewan, an LL.B. from Dalhousie Law School and an M.B.A. from the University of British Columbia.

Other news from the department people

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?